Cervical Spondylotic Arteriopathy
Conditions
Interventions
Group 1:Dingxuan granule (1 bag at a time, 2 times a day for 2 weeks)
Group 2:Betastine mesylate tablets (2 tablets at a time, 3 times a day for 2 weeks)
Sponsors
Wangjing Hospital, China Academy of Chinese Medical Sciences
Eligibility
Sex/Gender
All
Age
35 Years to 55 Years
Inclusion criteria
Inclusion criteria: 1) meet the above diagnostic criteria; 2) aged 35 to 55 years; 3) disease duration: 5 years; 4) if you have received other conservative treatment, you will have a washout period of more than 5 days; 5) signing informed consent.
Exclusion criteria
Exclusion criteria: 1) other types of cervical spondylosis; 2) cervical vertebra has dislocation, fracture, tuberculosis, acute cervical intervertebral disc herniation, infection and tumor; 3) patients with vertigo caused by otogenic, cerebral, traumatic, ocular, neurogenic and intracranial tumors; 4) subclavian artery stealing blood syndrome; 5) patients with severe heart, liver, brain and kidney complications and other serious diseases; 6) pregnant and mentally ill; 7) patients allergic to traditional Chinese medicine or betastine mesylate tablets.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cervical vertigo symptom and function scale;Quality of life scale sf-12; | — |
Countries
China
Contacts
Public ContactZhang Wei
Beijing University of Chinese Medicine
Outcome results
None listed